EANS-Voting Rights: Epigenomics AG / Release of a voting rights announcement according to article 26, section 1.1 WpHG (Securities Trading Act) with the aim of a Europe-wide distribution

--------------------------------------------------------------------------------
Notification of voting rights transmitted by euro adhoc. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Person/company obliged to make the notification:

-----------------------------------

Name: Federated Equity Management Company of Pennsylvania
Place: Pittsburgh, PA
State: USA

Company data:
-----------------------

Name: Epigenomics AG
Address: Kleine Präsidentenstraße 1, 10178 Berlin
Place: Berlin
State: Deutschland

Voting Rights: Release of a Voting Rights Notification in Accordance with § 26,
para. 1 WpHG (German Securities Trading Act) with the Aim of an Europe-wide
Distribution

Issuer:

Epigenomics AG
Kleine Präsidentenstr. 1
10178 Berlin
Germany

Voting Rights Notification:

On 08 April 2010 Federated Investors Inc., Pittsburgh, PA, USA, notified
Epigenomics AG in the name and on behalf of Federated Equity Management Company
of Pennsylvania, Pittsburgh, PA, USA, on the holding of voting rights held in
Epigenomics AG pursuant to § 21 para. 1 WpHG in connection with § 22 para. 1
sent. 1 no. 6 WpHG:

On 31 March 2010 the voting rights in Epigenomics AG held by Federated Equity
Management Company of Pennsylvania fell below the 5 per cent threshold of § 21
para. 1 WpHG and Federated Equity Management Company of Pennsylvania held at
this date 3.894 per cent of the voting rights (i.e. 1,716,890 voting rights of
the 44,092,085 shares outstanding at that date) in Epigenomics AG.

All 3.894 per cent of the voting rights (1,716,890 voting rights) are
attributed to Federated Equity Management Company of Pennsylvania pursuant to §
22 para. 1 sent. 1 no. 6 WpHG. Some of the voting rights are attributed to
Federated Equity Management Company of Pennsylvania by Federated Kaufmann Fund,
Pittsburgh, PA, USA, which holds directly 3 or more per cent of the voting
rights in Epigenomics AG.

Date of release: 12 April 2010

Epigenomics AG
The Executive Board

Contact:

Epigenomics AG
Dr. Achim Plum
Senior Vice President Corporate Development
Tel.: +49 (0)30 24345 368
Fax: +49 (0)30 24345 555
Email: achim.plum@epigenomics.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Epigenomics AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Branche: Biotechnology
ISIN: DE000A0BVT96
WKN: A0BVT9
Index: Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade